PIONEERING USE OF THE CLOUD FOR DEVELOPMENT OF COLLABORATIVE DRUG DISCOVERY ( CDD ) DATABASE - Collaborative Computational Technologies for Biomedical Research - page 361

64. Gupta RR , Gifford EM , Liston T , Waller CL , Bunin B , Ekins S . Using open source
computational tools for predicting human metabolic stability and additional
ADME/TOX properties. Drug Metab Dispos 2010 ; 38 : 2083 - 2090 .
65. Guha R , Howard MT , Hutchison GR , Murray - Rust P , Rzepa H , Steinbeck C . The
Blue Obelisk—Interoperability in chemical informatics. J Chem Inf Model 2006 ;
46 : 991 - 998 .
66. Sykora VJ , Leahy DE . Chemical Descriptors Library (CDL): A generic, open
source software library for chemical informatics. J Chem Inf Model 2008 ; 48 :
1931 - 1942 .
67. Melville JL , Hirst JD . TMACC: Interpretable correlation descriptors for quantita-
tive structure- activity relationships . J Chem Inf Model 2007 ; 47 : 626 - 634 .
68. Guangli M , Yiyu C . Predicting Caco - 2 permeability using support vector machine
and chemistry development kit. J Pharm Pharm Sci 2006 ; 9 : 210 - 221 .
69. Guha R . Flexible Web service infrastructure for the development and deployment
of predictive models. J Chem Inf Model 2008 ; 48 : 456 - 464 .
70. Spjuth O , Alvarsson J , Berg A , Eklund M , Kuhn S , Masak C . Bioclipse 2: A script-
able integration platform for the life sciences. BMC bioinform 2009 ; 10 : 397 .
71. Spjuth O , Helmus T , Willighagen EL , Kuhn S , Eklund M , Wagener J . Bioclipse: An
open source workbench for chemo- and bioinformatics. BMC Bioinform 2007 ; 8 : 59 .
72. Steinbeck C , Hoppe C , Kuhn S , Floris M , Guha R , Willighagen EL . Recent develop-
ments of the chemistry development kit (CDK)—An open-source java library for
chemo- and bioinformatics. Curr Pharm Des 2006 ; 12 : 2111 - 2120 .
73. Dong X , et al. Web service infrastructure for chemoinformatics . J Chem Inf Model
2007 ; 47 : 1303 - 1307 .
74. Lipinski CA , Lombardo F , Dominy BW , Feeney PJ . Experimental and computa-
tional approaches to estimate solubility and permeability in drug discovery and
development settings. Adv Drug Del Rev 1997 ; 23 : 3 - 25 .
75. Ballel L , Field RA , Duncan K , Young RJ . New small - molecule synthetic antimyco-
bacterials . Antimicrob Agents Chemother 2005 ; 49 : 2153 - 2163 .
76. Prathipati P , Ma NL , Keller TH . Global Bayesian models for the prioritization of
antitubercular agents. J Chem Inf Model 2008 ; 48 : 2362 - 2370 .
77. Maddry JA , et al. Antituberculosis activity of the molecular libraries screening
center network library. Tuberculosis (Edinburgh, Scotland) 2009 ; 89 : 354 - 363 .
78. Gupte A , et al. Inhibition of siderophore biosynthesis by 2 - triazole substituted
analogues of 5′ - O - [ N - (salicyl)sulfamoyl]adenosine: Antibacterial nucleosides
effective against Mycobacterium tuberculosis . J Med Chem 2008 ; 51 : 7495 - 7507 .
79. Ananthan S . High - throughput screening for inhibitors of Mycobacterium tubercu-
losis H37Rv . Tuberculosis (Edinburgh, Scotland) 2009 ; 89 : 334 - 353 .
80. Willand N . Synthetic EthR inhibitors boost antituberculous activity of ethionamide .
Nat Med 2009 ; 15 : 537 - 544 .
81. Sacchettini JC , Rubin EJ , Freundlich JS . Drugs versus bugs: In pursuit of the per-
sistent predator Mycobacterium tuberculosis . Nature Rev 2008 ; 6 : 41 - 52 .
82. Guiguemde

WA . Chemical genetics of Plasmodium falciparum . Nature

2010 ; 465 : 311 - 315 .
83. Gamo F - J . Thousands of chemical starting points for antimalarial lead identifi ca-
tion . Nature 2010 ; 465 : 305 - 310 .